LOPERAMIDE VIATRIS CONSEIL 2 mg, lyophilisat oral — plaquettes (PVC/polyamide/aluminium/PVC) avec opercule détachable en (Papier/PET/Aluminium) de 12 lyophilisats oraux

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930241929
  • CIP7 3024192
  • CIS 64433231

What the source publishes

Holder
VIATRIS SANTE
Active ingredients
CHLORHYDRATE DE LOPÉRAMIDE, LOPÉRAMIDE BASE
Form
lyophilisat
Package
plaquettes (PVC/polyamide/aluminium/PVC) avec opercule détachable en (Papier/PET/Aluminium) de 12 lyophilisats oraux
Routes
orale
Administrative status
authorised
Marketing status
Déclaration de commercialisation
Authorised on
2021-11-15

Names this record is found by

Complete source data
fr:ansm:packages:3400930241929
{
  "cis": "64433231",
  "cip7": "3024192",
  "form": "lyophilisat",
  "name": "LOPERAMIDE VIATRIS CONSEIL 2 mg, lyophilisat oral — plaquettes (PVC/polyamide/aluminium/PVC) avec opercule détachable en (Papier/PET/Aluminium) de 12 lyophilisats oraux",
  "cip13": "3400930241929",
  "holder": "VIATRIS SANTE",
  "routes": [
    "orale"
  ],
  "holders": [
    "VIATRIS SANTE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2021-11-15",
  "compositions": [
    {
      "name": "CHLORHYDRATE DE LOPÉRAMIDE",
      "nature": "SA",
      "strength": "2 mg",
      "linkageNumber": "1",
      "substanceCode": "00001",
      "dosageReference": "un lyophilisat",
      "pharmaceuticalElement": "lyophilisat"
    },
    {
      "name": "LOPÉRAMIDE BASE",
      "nature": "FT",
      "strength": "1,85 mg",
      "linkageNumber": "1",
      "substanceCode": "76119",
      "dosageReference": "un lyophilisat",
      "pharmaceuticalElement": "lyophilisat"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": null,
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "LOPERAMIDE VIATRIS CONSEIL 2 mg, lyophilisat oral",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquettes (PVC/polyamide/aluminium/PVC) avec opercule détachable en (Papier/PET/Aluminium) de 12 lyophilisats oraux",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2022-07-29",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "unknown",
  "activeIngredientNames": [
    "CHLORHYDRATE DE LOPÉRAMIDE",
    "LOPÉRAMIDE BASE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930241929"